Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Latest Content
This week’s Path Forward event featured Dr. Mike Ryan, executive director of the WHO, on why the pandemic is not over.
The Global Task Force on Pandemic Response, a newly formed U.S.-based public-private partnership organized by the U.S. Chamber of Commerce and supported by Business Roundtable, announced today that it is working with the Chamber’s U.S.-India Business Council and the U.S.-India Strategic Partnership Forum to take three immediate actions to help address the COVID-19 surge in India.
This Hill letter was sent to the Members of the U.S. House of Representatives, opposing H.R. 3, the "Lower Drug Costs Now Act." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.
This event focused on the American business community’s response to the devastating surge of coronavirus in India and school reopenings.
Learn more about the U.S.-Israel Business Council's bilateral health innovation dialogue.
WASHINGTON, D.C. – Myron Brilliant, Executive Vice President and Head of International Affairs at the U.S. Chamber of Commerce, issued the following statement calling on the administration to distribute U.S. vaccine supplies to international partners.
WASHINGTON, D.C. - The U.S. Chamber of Commerce strongly opposes H.R. 3, the “Lower Drug Costs Now Act of 2019,” which imposes government set price controls on prescription drugs. Members of Congress that refrain from cosponsoring this misguided legislation will receive credit for the Leadership component of the Chamber's “How They Voted” legislative scorecard. The following statement can be attributed to Neil Bradley, Executive Vice President and Chief Policy Officer, U.S. Chamber of Commerce:
This week’s Path Forward event focused on companies’ various strategies for encouraging employees to get vaccinated against COVID-19.
The U.S. Chamber of Commerce's U.S.-Egypt Business Council offers recommendations to enhance the U.S.-Egypt economic relationship.
A group of five experts hosted live “Ask Me Anything” sessions answering questions about COVID-19.
